These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33817137)

  • 21. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
    Jing JS; Ye W; Jiang YK; Ma J; Zhu MQ; Ma JM; Zhou H; Yu LQ; Yang YF; Wang SC
    Clin Lab; 2017 Nov; 63(11):1903-1909. PubMed ID: 29226636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma.
    Amr KS; Elmawgoud Atia HA; Elazeem Elbnhawy RA; Ezzat WM
    Genes Dis; 2017 Dec; 4(4):215-221. PubMed ID: 30258925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
    Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
    Hussein TD
    Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.
    Attallah AM; El-Far M; Omran MM; Abdelrazek MA; Attallah AA; Saeed AM; Farid K
    Tumour Biol; 2016 Sep; 37(9):12571-12577. PubMed ID: 27380057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation for clinical and prognostic implications of glypican-3 and α-fetoprotein in hepatocellular carcinoma: a new subtype?
    Ye L; Li D; Chen Y; Yu X
    Transl Cancer Res; 2020 May; 9(5):3443-3452. PubMed ID: 35117710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis.
    Sun B; Huang Z; Wang B; Yu Y; Lin S; Luo L; Wang Y; Huang Z
    Med Sci Monit; 2017 Feb; 23():850-855. PubMed ID: 28207681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    Mohamed AA; Omar AAA; El-Awady RR; Hassan SMA; Eitah WMS; Ahmed R; Khater A; Tantawi OMS; Mohamed AA
    J Transl Int Med; 2020 Mar; 8(1):32-40. PubMed ID: 32435610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC.
    Wang Y; Shen Z; Zhu Z; Han R; Huai M
    Hepat Mon; 2011 Mar; 11(3):195-9. PubMed ID: 22087143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
    Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Guo Z; Wang J; Li L; Liu R; Fang J; Tie B
    World J Clin Cases; 2020 Aug; 8(16):3493-3502. PubMed ID: 32913856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
    Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
    Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPC3 gene expression and allelic discrimination of FZD7 gene in Egyptian patients with hepatocellular carcinoma.
    Ramadan A; Ghanem HM; Mohamed AA; Elshobaky M; El Agawy W; Gawad EAHA; Eldeeb HH; Ezz Al Arab MR; Kamal MM
    Rep Pract Oncol Radiother; 2023; 28(4):485-495. PubMed ID: 37795234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.